Health and Development Novartis Symposium 4/14/01 Access to Medicine – The Role of Patent Rules Sophia Tickell- Oxfam GB. Trade Talks at Doha. Test of legitimacy of WTO & multilateral trading system. Patents/Medicines by far the biggest single issue. Outcome: Declaration.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
“We Agree That the TRIPS Agreement Does Not and Should Not Prevent Members From Taking Measures to Protect Public Health”
Poor people buy medicines & struggle to do so in LDCs and DCs
Luweero, Uganda – ¾ poor families sell food crops to buy medicines
Colombia – 1 in 5 on/below poverty line – medicines = greatest household health expenditure.
Poor governments do too
61 DCs average medicine spend = S$102. Why does it matter? – Poor people can barely afford medicines
Local generics industry allows governments to negotiate over prices:
Nelfinavir & Indinavir – Brazil
Cipro – US$1.77 per tab to US$0.95 – US
2001 – Growing recognition of social function of generics
South Africa - Nelson Mandela in the dock for attempting to get cheap drugs for 4.2m AIDS sufferers
Dominican Republic threat to textiles
Brazil - Successful HIV/AIDS programme under threat 50% mortality cut
impact of length and scope of pharmaceutical patenting and amend TRIPS to ensure access